Eikon Therapeutics Inc (EIKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Operating Expenses | 338,945 | 260,343 |
| Operating Income | -338,945 | -260,343 |
| Interest Expense | 837 | 31 |
| Other Income | 15,534 | 16,560 |
| Pre-tax Income | -324,248 | -243,814 |
| Net Income Continuous | -324,248 | -243,814 |
| Net Income | $-324,248 | $-243,814 |
| EPS Basic Total Ops | -115.29 | -96.76 |
| EPS Basic Continuous Ops | -112.04 | -96.76 |
| EPS Diluted Total Ops | -115.29 | -96.76 |
| EPS Diluted Continuous Ops | -112.04 | -96.76 |
| EPS Diluted Before Non-Recurring Items | -115.29 | N/A |
| EBITDA(a) | $-314,769 | $-234,951 |